COCRYSTAL PHARMA, INC. Accrued Fees and Other Revenue Receivable
COCRYSTAL PHARMA, INC. (COCP) had Accrued Fees and Other Revenue Receivable of $25.00 thousand as of 2016-06-30, per its 10-Q filed 2016-08-09.
Discontinued › Balance Sheet › Assets
us-gaap:AccruedFeesAndOtherRevenueReceivable · last filed 2016-08-09
- 2016-06-30: Accrued Fees and Other Revenue Receivable $25.00K.
- 2016-03-31: Accrued Fees and Other Revenue Receivable $24.00K.
- 2015-12-31: Accrued Fees and Other Revenue Receivable $27.00K.
- 2015-09-30: Accrued Fees and Other Revenue Receivable $25.00K.
| Period end | Accrued Fees and Other Revenue Receivable |
|---|---|
| 2016-06-30 | $25.00K 10-Q · filed 2016-08-09 |
| 2016-03-31 | $24.00K 10-Q · filed 2016-05-10 |
| 2015-12-31 | $27.00K 10-K · filed 2016-03-15 |
| 2015-09-30 | $25.00K 10-Q · filed 2015-11-16 |
| 2015-06-30 | $26.00K 10-Q · filed 2015-08-14 |
| 2015-03-31 | $26.00K 10-Q · filed 2015-05-14 |
| 2014-12-31 | $27.00K 10-K · filed 2015-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |